SSKN
STRATA Skin Sciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.01
+0.00%Year over year
Reported trailing growth
- Revenue
- -8.5%
- EBITDA
- +80.2%
- EBIT
- +34.5%
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -24.3%
- EBITDA
- —
- EPS
- -10.1%
Three-year CAGR
- Revenue
- -5.3%
- EBITDA
- -46.1%
- EBIT
- +37.0%
- Net income
- +37.9%
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025